During the past decade, Norton Cancer Institute-Downtown conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Cancer Institute-Downtown" #1 sponsor was "Pfizer" with 2 trials, followed by "Arcus Biosciences, Inc." with 1 trials sponsored, "BicycleTx Limited" with 1 trials sponsored, "Calithera Biosciences, Inc" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Cancer Institute-Downtown" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Norton Cancer Institute-Downtown" are "Advanced Solid Tumor" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Breast Cancer" (1 trials), "Carcinoma" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Norton Cancer Institute-Downtown" in a lesser frequency.

Most popular intervention types in "Norton Cancer Institute-Downtown" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (2 trials), "Zimberelimab" (2 trials), "AB308" (1 trials), "Atezolizumab" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norton Cancer Institute-Downtown" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Norton Cancer Institute-Downtown". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Norton Cancer Institute-Downtown, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Cancer Institute-Downtown, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".